Secondary analyses revealed similar results in patients without baseline HF (n = 158,543 for DPP-4 inhibitors; n = 158,543 for GLP-1 agonists; HR, 0.85; 95% CI 0.82, 0.89). The gene discussed is GCG; the disease is hydrops fetalis.